These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5905779)

  • 21. Selective decrease in serum immunoglobulin G1. A tissue nonspecific tumor marker detecting early stages of gynecologic malignant disease with high efficiency.
    Schauenstein E; Lahousen M; Weblacher M; Steinschifter W; Estelberger W; Schauenstein K
    Cancer; 1996 Aug; 78(3):511-6. PubMed ID: 8697398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Malignant gynecologic tumors].
    Merz WR
    Rev Med Suisse Romande; 1969 May; 89(5):313-8. PubMed ID: 5385882
    [No Abstract]   [Full Text] [Related]  

  • 23. [Relation of serum immunoglobulins and the activity, progress and treatment of gynecologic tumors].
    Tosner J; Fixa B; Turková M
    Cesk Gynekol; 1983 Sep; 48(8):574-80. PubMed ID: 6627434
    [No Abstract]   [Full Text] [Related]  

  • 24. [The computerized radionephrogram. Uses in gynecologic oncology].
    Ciambellotti E; Giana M
    Minerva Ginecol; 1983 Mar; 35(3):119-26. PubMed ID: 6856182
    [No Abstract]   [Full Text] [Related]  

  • 25. [Our experience with the glucose-6-phosphate and 6-phosphogluconate dehydrogenase tests in the diagnosis of gynecologic carcinoma].
    Misinger I; Trnková M; Skoda V
    Cesk Gynekol; 1967 Feb; 32(1):10-4. PubMed ID: 6044933
    [No Abstract]   [Full Text] [Related]  

  • 26. Gynecologic malignancy presenting as hernia.
    Plaxe SC; Dottino PR; Cohen CJ
    Am Fam Physician; 1993 Jan; 47(1):51, 54, 57. PubMed ID: 8418586
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-Hodgkin lymphoma in a gynecologic service. A report of three cases.
    Di Vagno G; Cormio G; Di Gesù A; Loverro G; Caniglia A; Selvaggi L
    Panminerva Med; 1998 Sep; 40(3):247-9. PubMed ID: 9785926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant gynecologic disease: applications of magnetic resonance imaging.
    Troiano RN; Smith R
    Top Magn Reson Imaging; 1995; 7(1):44-53. PubMed ID: 7873206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. False positive malignant peritoneal cytology and psammoma bodies in benign gynecologic disease.
    Fanning J; Markuly SN; Hindman TL; Galle PC; McRae MA; Visnesky PM; Hilgers RD
    J Reprod Med; 1996 Jul; 41(7):504-8. PubMed ID: 8829063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine-needle aspiration biopsy in gynecologic oncology.
    Wilson CL; Currie JL
    N C Med J; 1982 May; 43(5):349-50. PubMed ID: 6954366
    [No Abstract]   [Full Text] [Related]  

  • 31. The feasibility of open laparoscopy in gynecologic-oncologic patients.
    Decloedt J; Berteloot P; Vergote I
    Gynecol Oncol; 1997 Jul; 66(1):138-40. PubMed ID: 9234934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The enlarged leg in gynecologic oncology].
    Almendral AC
    Gynakologe; 1980 Jun; 13(2):106-10. PubMed ID: 7349845
    [No Abstract]   [Full Text] [Related]  

  • 33. [The value of ultrasound diagnosis and computed tomography in gynecologic oncology].
    Jirous J; Heger L; Chalupa M
    Arch Geschwulstforsch; 1983; 53(5):471-7. PubMed ID: 6651474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasonic examination of the abdomen in malignant disease. Part 3. The female reproductive system.
    John C
    Radiography; 1983 May; 49(581):109-16. PubMed ID: 6878647
    [No Abstract]   [Full Text] [Related]  

  • 35. [Early diagnosis and prevention of female genital neoplasms in a clinic: preliminary evaluations].
    Maggi R; Milani R; Galluzzi A; Colombo N; Gilardi L; Cristofori E
    Ann Ostet Ginecol Med Perinat; 1982; 103(2):140-7. PubMed ID: 7114709
    [No Abstract]   [Full Text] [Related]  

  • 36. Photomedical approaches for the diagnosis and treatment of gynecologic cancers.
    Hornung R
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):165-77. PubMed ID: 12476797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Organization of the detection of gynecologic carcinomas in the hospital environment].
    Riga C
    Minerva Ginecol; 1971 Jul; 23(13):571-4. PubMed ID: 5122453
    [No Abstract]   [Full Text] [Related]  

  • 38. Malignant ascites in female patients: a seven-year review.
    Wilailak S; Linasmita V; Srivannaboon S
    J Med Assoc Thai; 1999 Jan; 82(1):15-9. PubMed ID: 10087733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A diagnostic evaluation of serum human telomerase reverse transcriptase mRNA as a novel tumor marker for gynecologic malignancies.
    Miura N; Kanamori Y; Takahashi M; Sato R; Tsukamoto T; Takahashi S; Harada T; Sano A; Shomori K; Harada T; Kigawa J; Ito H; Terakawa N; Hasegawa J; Shiota G
    Oncol Rep; 2007 Mar; 17(3):541-8. PubMed ID: 17273731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine-needle aspiration cytology versus core biopsies in the evaluation of recurrent gynecologic malignancies.
    Malmström H
    Gynecol Oncol; 1997 Apr; 65(1):69-73. PubMed ID: 9103393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.